BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Navega Therapeutics

Navega Therapeutics logo



Gene Therapy Startups

Navega Tx is a preclinical stage company pursuing a radically different approach to treat chronic pain and tackle the opioid epidemic.
We have developed a patented, non-permanent gene therapy to target pain. Startup Navega Therapeutics is the first to apply a variant of CRISPR (and ZFs) that acts as an epigenetic modulator to treat pain.

Posts Mentioning This Company

A Race For Better Gene Editing Tech Is On

A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least in research laboratories, where scientists efficiently adopted CRISPR technology to manipulate genes of interest. Still, applying it for humans is associated with greater risks and faces ethical issues. However, alongside …
SHARE Share in Facebook Share in Twitter Share in LinkedIn Send by email